FDA.reportPublic FDA data

empagliflozin 10 MG / linagliptin 5 MG Oral Tablet [Glyxambi]

RxCUI
1602115
RxNorm name
empagliflozin 10 MG / linagliptin 5 MG Oral Tablet [Glyxambi]
Display name
empagliflozin 10 MG / linagliptin 5 MG Oral Tablet [Glyxambi]
Full name
empagliflozin 10 MG / linagliptin 5 MG Oral Tablet [Glyxambi]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:39:24

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
GlyxambiEMPAGLIFLOZIN AND LINAGLIPTINBoehringer Ingelheim Pharmaceuticals, Inc.ddbab689-f76c-488c-9613-4168d41dd7302026-01-20Warnings, Adverse reactionsExact identifier
rxcui: 1602115

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
ddbab689-f76c-488c-9613-4168d41dd730Glyxambi 10 MG / 5 MG Oral Tablet [PSN] · empagliflozin 10 MG / linagliptin 5 MG Oral Tablet [Glyxambi] [SBD] · Glyxambi (empagliflozin 10 MG / linagliptin 5 MG) Oral Tablet [SY]323These highlights do not include all the information needed to use GLYXAMBI safely and effectively. See full prescribing information for GLYXAMBI. GLYXAMBI ® (empagliflozin and linagliptin tablets), for oral use Initial U.S. Approval: 201520260120